Hagar I. Labouta
- Pharmaceutical Science top 1%
- Biomedical Engineering top 10%
- Molecular Biology
- Materials Chemistry
- Biomaterials top 5%
- Co-authors
- Marc SchneiderLabiba K. El‐KhordaguiTobias KrausDavid T. CrambKristina D. RinkerNasimeh AsgarianNasrin HooshmandMostafa A. El‐Sayed
- Topics
- Nanoparticle-Based Drug Delivery (9 papers)Advancements in Transdermal Drug Delivery (9 papers)Gold and Silver Nanoparticles Synthesis and Applications (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaACS NanoAdvanced Drug Delivery Reviews
In The Last Decade
Hagar I. Labouta
43 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 136
- Pharmaceutical Science 322
- Biomedical Engineering 301
- Molecular Biology 267
- Materials Chemistry 257
- Biomaterials 201
Countries citing papers authored by Hagar I. Labouta
This map shows the geographic impact of Hagar I. Labouta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hagar I. Labouta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hagar I. Labouta more than expected).
Fields of papers citing papers by Hagar I. Labouta
This network shows the impact of papers produced by Hagar I. Labouta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hagar I. Labouta. The network helps show where Hagar I. Labouta may publish in the future.
Co-authorship network of co-authors of Hagar I. Labouta
This figure shows the co-authorship network connecting the top 25 collaborators of Hagar I. Labouta. A scholar is included among the top collaborators of Hagar I. Labouta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hagar I. Labouta. Hagar I. Labouta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 17 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 39 | |
| 6 | 26 | |
| 7 | 4 | |
| 8 | 10 | |
| 9 | 35 | |
| 10 | 16 | |
| 11 | 38 | |
| 12 | 57 | |
| 13 | 26 | |
| 14 | RELATING QUANTUM DOT ASSOCIATION WITH HUMAN ENDOTHELIAL CELLS WITH THEIR CYTOTOXIC EFFECTS | 1 |
| 15 | 16 | |
| 16 | 117 | |
| 17 | 43 | |
| 18 | 22 | |
| 19 | 46 | |
| 20 | 15 |
About Hagar I. Labouta
Hagar I. Labouta is a scholar working on Pharmaceutical Science, Biomaterials and Obstetrics and Gynecology, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Advancements in Transdermal Drug Delivery (9 papers) and Gold and Silver Nanoparticles Synthesis and Applications (5 papers). The work is most often cited by research in Pharmaceutical Science (322 citations), Biomaterials (201 citations) and Dermatology (124 citations). Hagar I. Labouta has collaborated with scholars based in Canada, Egypt and Germany. Frequent co-authors include Marc Schneider, Labiba K. El‐Khordagui, Tobias Kraus, David T. Cramb, Kristina D. Rinker, Nasimeh Asgarian, Nasrin Hooshmand, Mostafa A. El‐Sayed, Shahla Shojaei and Marta Gómez-Garcı́a. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.